Unicycive Therapeutics (UNCY) Market Capitalization (2021 - 2026)

Unicycive Therapeutics (UNCY) has reported Market Capitalization for 6 consecutive years, with $130.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 94.08% year-over-year to $130.6 million; the trailing twelve-month figure through Jun 2026 stood at $130.6 million (up 94.08% YoY), and the FY2025 full-year result was $91.7 million, up 72.31% from the prior year.
• Market Capitalization retreated to $130.6 million in Q2 2026 per UNCY's latest filing, from $166.1 million in the prior quarter.
• Across five years, Market Capitalization topped out at $166.1 million in Q1 2026 and bottomed at $8.2 million in Q4 2022.
• Historically, Market Capitalization has averaged $51.9 million across 5 years, with a median of $36.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization slumped 78.99% in 2022, then jumped 235.76% in 2023.
• Over 5 years, Market Capitalization stood at $8.2 million in 2022, then surged by 158.88% to $21.3 million in 2023, then surged by 149.85% to $53.2 million in 2024, then soared by 72.31% to $91.7 million in 2025, then jumped by 42.52% to $130.6 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $130.6 million, $166.1 million, and $91.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.